Overview

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Fluoxetine